Safety Alert

#	Title	Type of news	Date
87	Safety Signal of Agomelatine and the Risk of Hypertension	Signal	2021-02-17
86	Safety Signal of Indapamide and the Risk of Rhabdomyolysis	Signal	2021-01-21
85	Safety Signal of Theophylline and the Risk of Encephalopathy	Signal	2021-01-13
84	Safety Signal of Amitriptyline and the Risk of Drug Reaction with Eosinophilia and Systemic Symptoms	Signal	2021-01-03
83	Safety Signal of Nivolumab and the Risk of Hypoparathyroidism	Signal	2021-01-03
82	Potential Risk of Tumor Lysis Syndrome Associated with the Use Pazopanib	Precautions	2020-11-09
81	Baricitinib (Olumiant®) and increased risk of diverticulitis: Recommendations for Healthcare Professionals from the SFDA	Precautions	2020-09-02
80	Safety Signal of Hypokalemia associated with the use of Ceftriaxone	Signal	2020-09-07
79	Safety Signal of Molluscum Contagiosum associated with the use of Fingolimod	Signal	2020-09-07
78	Safety Signal of Rhabdomyolysis associated with the use of Pembrolizumab	Signal	2020-09-07